Skip to content
stoqly

Silicon Labs

SLAB Nasdaq Semiconductors Financials FY2016–FY2025

Silicon Labs' revenue rose 34.3% to $785 million in fiscal 2025. Its operating margin was −9.0%, up from −28.3% a year earlier. Free cash flow was $66 million. The diluted share count rose 1.6%.

Last close · Oct 23, 2026

$221.27

0.1%
Value it Compare
Revenue Total sales reported in the income statement.
$785M
34.3% vs prior year
Operating margin Operating income as a share of revenue.
−9.0%
19.3 pts
Net income Profit after all expenses, interest and tax.
−$64.9M
Free cash flow Cash from operations minus capital spending.
$65.8M
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
−7.0%
8.9 pts
Market cap Last close times the latest diluted share count, so it is approximate.
$7.3B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
—

About these figures. Silicon Labs had only convertible notes as debt; none were current at the end of 2022 or on the balance sheet after 2022, and none were long-term at the end of 2021 (checked against its balance sheets).

What Silicon Labs does

No business description yet.

Legal name
SILICON LABORATORIES INC.
Fiscal year ends
January 3, 2026
Latest annual report
—
Accession · CIK
0001038074-26-000005
0001038074

Revenue and margins

Silicon Labs had $785M of revenue in fiscal 2025, up 34.3% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $65.8M in fiscal 2025, 8.4% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Silicon Labs returned $0.0M to shareholders in fiscal 2025, 0% of free cash flow. The diluted share count rose 1.7%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Value Silicon Labs yourself

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.

Discounted cash flow

Value per share

—

Adds net cash of $291M and divides by 32.7M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Balance sheet

Cash, debt and the ratios that show how comfortably Silicon Labs can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $2.0B$1.2B$350M$289M$291M
Debt incl. finance leases $451M$530M$0.0M$0.0M$0.0M
Net debt / EBITDA −53.5x−3.8x−13.0x——
Debt / equity 0.2x0.4x0.0x0.0x0.0x
Interest coverage −1.1x17.7x−4.4x−126.3x−72.4x
Current ratio 3.4x7.9x4.5x6.2x4.7x
Quick ratio 3.3x7.3x3.3x5.1x4.0x
Total assets $3.0B$2.2B$1.4B$1.2B$1.3B
Total liabilities $746M$764M$234M$143M$175M
Shareholders' equity $2.2B$1.4B$1.2B$1.1B$1.1B
Net debt (− = net cash) −$1.6B−$662M−$350M−$289M−$291M

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$4.2M

4 insiders

Of sales under plans

59%

$2.5M

DateInsiderTradeSharesPriceValueFiling
Aug 14, 2026 Robert J ConradSr VP and General Manager Sold plan 6,581 $218.21 $1.4M Form 4
May 18, 2026 Robert Matthew JohnsonPresident & CEO, Director Sold 8,024 $216.83 $1.7M Form 4
Jan 13, 2026 Nina RichardsonDirector Sold plan 1,355 $149.00 $0.2M Form 4
Dec 5, 2025 Brandon TolanySr VP WW Sales & Marketing Sold plan 1,954 $141.49 $0.3M Form 4
Dec 4, 2025 Brandon TolanySr VP WW Sales & Marketing Sold plan 4,246 $140.17 $0.6M Form 4

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY23FY24FY25
Net income is positive ✕ ✕ ✕
Cash from operations is positive ✕ ✕ ✓
Return on assets rose ✕ ✕ ✓
Cash from operations exceeds net income ✓ ✓ ✓
Debt fell relative to assets ✓ ✕ ✕
Current ratio rose ✕ ✓ ✕
Share count didn't rise ✓ ✕ ✕
Gross margin rose ✕ ✕ ✓
Revenue rose relative to assets ✓ ✓ ✓
F-score 4 / 93 / 95 / 9
Accruals ratio −0.2%−13.3%−12.9%
Altman Z'' 10.6112.4211.34

Similar companies

Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
Silicon Labs SLAB $7.3B 34.3% −9.0% 8.4% −7.0% — 5
Rambus RMBS $9.4B 27.1% 36.8% 47.1% 34.3% 40.8x 5 Compare →
Allegro MicroSystems ALGM $5.9B 22.8% 2.1% 14.0% 1.3% — 7 Compare →
Universal Display OLED $4.1B 0.5% 38.2% 23.7% 17.9% 21.0x 3 Compare →
MACOM Technology Solutions MTSI $18.5B 32.6% 13.4% 19.9% 9.8% 75.2x 5 Compare →

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $698M $769M $868M $474M $511M $721M $1.0B $782M $584M $785M
Gross profit $422M $454M $521M $280M $295M $425M $643M $461M $312M $457M
Research and development $200M $210M $238M $206M $235M $273M $332M $338M $332M $353M
Operating income $66.3M $85.0M $85.2M −$88.6M −$107M −$32.8M $119M −$24.2M −$166M −$70.5M
Interest expense $2.6M $3.9M $19.7M $20.2M $34.1M $31.0M $6.7M $5.6M $1.3M $1.0M
Pretax income $64.5M $76.9M $72.2M −$96.0M −$130M −$44.4M $130M −$26.6M −$155M −$57.9M
Income tax $3.0M $29.8M −$11.4M $7.0M −$14.6M $13.4M $38.4M $7.9M $36.2M $7.0M
Net income $61.5M $47.1M $83.6M $19.3M $12.5M $2.1B $91.4M −$34.5M −$191M −$64.9M
Diluted EPS $1.45 $1.09 $1.90 $0.43 $0.28 $47.78 $2.54 −$1.09 −$5.93 −$1.98
Diluted shares 0.04B 0.04B 0.04B 0.04B 0.04B 0.04B 0.04B 0.03B 0.03B 0.03B
Cash flow
Cash from operations $129M $190M $174M $167M $136M $91.2M $141M −$30.3M −$13.9M $95.7M
Capital expenditure $10.9M $12.3M $24.5M $15.3M $18.1M $28.6M $26.5M $22.3M $11.7M $29.9M
Free cash flow $118M $177M $149M $151M $118M $62.6M $115M −$52.6M −$25.7M $65.8M
Depreciation and amortization $40.5M $41.9M $53.9M $52.9M $58.8M $62.6M $56.6M $51.1M $48.6M $38.1M
Stock-based compensation $39.6M $44.8M $50.1M $44.3M $49.5M $56.8M $60.5M $48.2M $61.5M $80.3M
Acquisitions $6.5M $15.2M $240M $2.5M $317M $0.0M $0.0M $0.0M $0.0M $0.0M
Share buybacks $40.5M $0.0M $39.3M $26.7M $16.3M $1.2B $883M $217M $0.0M $0.0M
Dividends paid $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Dividends and buybacks $40.5M $0.0M $39.3M $26.7M $16.3M $1.2B $883M $217M $0.0M $0.0M
Balance sheet
Cash and short-term investments $295M $764M $614M $726M $725M $2.0B $1.2B $350M $289M $291M
Total debt $72.5M $342M $355M $368M $563M $451M $530M $0.0M $0.0M $0.0M
Finance lease liabilities $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Current assets $491M $948M $827M $944M $976M $2.2B $1.5B $738M $602M $674M
Current liabilities $140M $162M $145M $138M $285M $669M $186M $164M $97.9M $144M
Inventory $59.6M $73.1M $75.0M $73.1M $47.9M $49.3M $100M $194M $106M $95.6M
Property and equipment, net $130M $128M $139M $136M $136M $147M $152M $146M $132M $129M
Total assets $1.1B $1.5B $1.6B $1.7B $2.0B $3.0B $2.2B $1.4B $1.2B $1.3B
Total liabilities $255M $582M $557M $560M $794M $746M $764M $234M $143M $175M
Shareholders' equity $827M $953M $1.1B $1.1B $1.2B $2.2B $1.4B $1.2B $1.1B $1.1B
Margins
Gross margin 60.4% 59.1% 60.1% 59.1% 57.7% 59.0% 62.7% 58.9% 53.4% 58.2%
Operating margin 9.5% 11.1% 9.8% −18.7% −21.0% −4.6% 11.7% −3.1% −28.3% −9.0%
EBITDA margin 15.3% 16.5% 16.0% −7.5% −9.4% 4.1% 17.2% 3.4% −20.0% −4.1%
Net margin 8.8% 6.1% 9.6% 4.1% 2.5% 293.7% 8.9% −4.4% −32.7% −8.3%
FCF margin 16.9% 23.1% 17.2% 31.9% 23.0% 8.7% 11.2% −6.7% −4.4% 8.4%
Returns
Return on capital 10.5% 9.2% 12.7% −9.0% −9.4% −3.1% 12.3% −2.4% −15.9% −7.0%
Return on capital employed 7.3% 7.3% 6.0% −5.9% −6.6% −1.6% 5.6% −1.5% −13.8% −6.3%
Return on equity 7.7% 5.3% 8.3% 1.8% 1.1% 124.1% 5.1% −2.6% −16.7% −6.0%
Return on assets 5.9% 3.6% 5.3% 1.2% 0.7% 85.5% 3.6% −1.9% −14.3% −5.2%
Growth
Revenue growth 8.2% 10.2% 12.9% −45.4% 7.8% 41.1% 42.1% −23.6% −25.3% 34.3%
Net income growth 107.9% −23.4% 77.5% −77.0% −35.0% 16,797.3% −95.7% −137.8% — —
EPS growth 110.1% −24.8% 74.3% −77.4% −34.9% 16,964.3% −94.7% −142.9% — —
FCF growth 25.3% 50.3% −15.9% 1.4% −22.2% −46.8% 83.2% −145.9% — —
Share count change −1.3% 2.3% 1.6% 0.6% 0.2% −0.1% −18.7% −11.8% 1.2% 1.7%
Financial health
Net debt / EBITDA −2.1x −3.3x −1.9x — — −53.5x −3.8x −13.0x — —
Debt / equity 0.1x 0.4x 0.3x 0.3x 0.5x 0.2x 0.4x 0.0x 0.0x 0.0x
Interest coverage 25.6x 22.0x 4.3x −4.4x −3.1x −1.1x 17.7x −4.4x −126.3x −72.4x
Current ratio 3.5x 5.8x 5.7x 6.9x 3.4x 3.4x 7.9x 4.5x 6.2x 4.7x
Quick ratio 3.1x 5.4x 5.2x 6.3x 3.3x 3.3x 7.3x 3.3x 5.1x 4.0x
Capital allocation
Capex / revenue 1.6% 1.6% 2.8% 3.2% 3.5% 4.0% 2.6% 2.9% 2.0% 3.8%
Stock comp / revenue 5.7% 5.8% 5.8% 9.4% 9.7% 7.9% 5.9% 6.2% 10.5% 10.2%
Payouts / FCF 34.4% 0.0% 26.4% 17.7% 13.9% 1,836.5% 769.9% — — 0.0%
Quality scores
Piotroski F-score 9.0 5.0 6.0 5.0 4.0 7.0 6.0 4.0 3.0 5.0
Altman Z'' 8.4 7.3 7.1 6.8 5.1 9.0 8.3 10.6 12.4 11.3
Accruals ratio −6.4% −10.9% −5.7% −8.9% −6.7% 81.8% −2.0% −0.2% −13.3% −12.9%

Source: SEC EDGAR XBRL filings (CIK 0001038074). Data updated October 17, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move · ↵ to open